Interrogation of the tumor microenvironment (TME) reveals considerable interplay between PD-1 and PD-L1 signaling (6), and although multiple molecules contribute to this immunosuppressive milieu, PD-L1 expression in some tumors is the single biomarker most closely associated with response to PD-1 blockade (6–8). Here, CD274 is linked to neoplasm.